Penserra Capital Management LLC Arcutis Biotherapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$14.98 - $25.5 $17,301 - $29,452	-1,155 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $192 - $271	10 Added 0.87%	1,155 $27,000
Q2 2021 Aug 12, 2021	BUY	$24.42 - $34.75 $366 - $521	15 Added 1.33%	1,145 $31,000
Q1 2021 May 13, 2021	BUY	$24.47 - $36.98 $3,181 - $4,807	130 Added 13.0%	1,130 $32,000
Q4 2020 Feb 12, 2021	BUY	$17.82 - $31.73 $17,820 - $31,730	1,000 New	1,000 $28,000

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.